Tag : 上海夜网EQ

Men’s basketball: Hayes cements his legacy in final season

first_imgAfter a rough beginning, Nigel Hayes turned himself and his team around in route to a fourth consecutive sweet 16, capping his senior season with a game-winning shot and earning the title of the Badger Herald’s Male Athlete of the Year.Throughout the year, Nigel Hayes became one of the biggest question marks for the Badgers, struggling to find his jumper and proving to be a liability at the line. As the season wore on, Wisconsin fans longed for the player they saw in the second half of the 2015-16 season when he led a young team to the Sweet 16, or the sophomore who stole the show on the Badger’s run to the NCAA championship.Yes it was clear, Hayes no longer had the supporting cast of guys like Kaminsky, Gasser and Decker. But if his college career up until this point was any indication, the senior from Toledo, Ohio was more than ready to take the reins.Hayes: In ‘one-and-done’ era, Nigel Hayes’ return isn’t so simpleThere is no doubt Nigel Hayes’ decision to return for his senior season was one the best outcomes for the Read…As his final season in Wisconsin began, expectations peaked for a team whose leaders (Hayes and Koenig), have never lost in the first round of the NCAA tournament. With a talented group of young players including sophomore Ethan Happ who burst onto the scene in his freshman campaign, Hayes and company were poised to continue the streak of success deep into the playoffs.Living up to those expectations, the Badgers jumped out to one of their best starts in program history with a record of 22-3. With the team rolling behind the play of Ethan Happ and Bronson Koenig, Hayes struggled to find that elite talent we’ve known for three years.The biggest wakeup call came at the end of the season when Wisconsin lost five of their last seven, and a team built on success and consistency couldn’t find either. With the Big Ten and NCAA tournaments knocking at their door, the Badgers were scrambling for answers, and where better to look than Nigel Hayes.Despite Hayes’ struggles from the line, 59 percent, the Toledo native was not settling for a late season collapse to cap off his historic career.Men’s basketball: Experts see potential NBA futures for Hayes, KoenigWhile Nigel Hayes garnered most of the preseason attention regarding a future basketball career in the NBA, Bronson Koenig quietly Read…Like most great college and professional players, Hayes turned it on when it mattered the most. After falling to the Michigan Wolverines in the Big Ten Championship game, the Badgers had their confidence back, and a chip on their shoulder after being named an eight seed in the NCAA Tournament.Similar to past years, the tournament was where Hayes came alive. After breezing by Virgina Tech, the Badgers faced off against the No. 1 overall seed Villanova in just the second round. After a turbulent season from the line and the field, Hayes shot over 50 percent from the field against the Wildcats, scoring 19 points including a Jordan-esque baseline fake to seal the deal against the top seed.Top five sports moments this semesterThe University of Wisconsin Athletic Department had a lot to celebrate this semester, even if none of those involved a Read…The Villanova game, like Hayes’ season, was a rollercoaster. A run here, a slump there, but in the end the veteran proved his worth, cementing his legacy in Wisconsin basketball.Along with a career shot to take down a one seed, here’s a list of some of Hayes’ notable achievements in his final year as a Badger, making him our Male Athlete of the Year.2017 NCAA Tournament All-East Region Team• 2017 Wooden Award Midseason Top-25• 2017 Player of the Year watch lists (Lute Olsen and Naismith)• 2017 Karl Malone Power Forward of the Year Watch List• 2017 Big Ten All-Tournament Team• 2017 Third-Team All-Big Ten• 2017 Preseason Big Ten Player of the Year• 2017 Senior CLASS Award Final 10• 2017 NABC Division 1 All-District Second Team[UPDATE] Hayes blows up Twitter with #BlackLivesMatter discussionFor six hours Thursday evening, University of Wisconsin star basketball forward Nigel Hayes tweeted 44 times supporting the Black Lives Read…last_img read more

Officials: Cold medicine can harm toddlers
first_img“The basic question is why should a product be so relentlessly marketed when it’s not safe or effective?” said Dr. Joshua Sharfstein, Baltimore’s health commissioner. “It does not make sense, in the absence of information, to say `consult a physician,’ because they do not have superhuman powers. They cannot make a product safe or effective.” The Consumer Healthcare Products Association, which represents makers of over-the-counter medicines, backs the recommendation that the cold and cough treatments not be used in children younger than 2. Separately, for antihistamines, the group recommends adding a warning that the drugs not be used to sedate young children, president Linda Suydam said. An FDA review of side-effect records filed with the agency between 1969 and September 2006, found 54 reports of deaths in children associated with decongestant medicines made with pseudoephedrine, phenylephrine or ephedrine. It also found 69 reports of deaths associated with antihistamine medicines containing diphenhydramine, brompheniramine or chlorpheniramine. Most of the deaths were children younger than 2. The Baltimore petition came on the heels of a Centers for Disease Control and Prevention report that found more than 1,500 toddlers and babies wound up in emergency rooms over a two-year period because of the drugs. 160Want local news?Sign up for the Localist and stay informed Something went wrong. Please try again.subscribeCongratulations! You’re all set! HEALTH: The FDA is concerned about the effects of decongestants and antihistamines. By Andrew Bridges THE ASSOCIATED PRESS WASHINGTON – Very young children simply should not take some commonly used cold and cough medicines, federal health officials say in recommending that the “consult your physician” advice to parents on the labels be dropped. The preliminary recommendation, from Food and Drug Administration safety officials, would apply to decongestant use in children under 2, and antihistamines in those younger than 6, according to agency documents released Friday. The more than 350 pages of documents are part of a broad and ongoing FDA examination of whether the roughly 800 medicines, many popular and widely used, are safe and effective in treating children’s colds and coughs. FDA advisers are to take up the issue during an Oct. 18-19 meeting. The FDA has not made a final decision on any label changes. Action is likely, pending a recommendation from outside experts. The review came in response to a recently filed petition by Baltimore city officials, who charged that many over-the-counter cough and cold remedies can harm toddlers and preschoolers. Those officials, joined by the American Academy of Pediatrics, cite evidence that suggests the drugs are not only risky but also don’t work in the very young. last_img